Tag Archives: BioGenex

April, 2016

  • 4 April

    BioGenex Launches Two New Antibodies for Cancer Diagnosis

    FREMONT, Calif., April 4, 2016 /PRNewswire/ — BioGenex, a global leader and innovator in molecular pathology and cancer diagnostics, announced the release of two new antibodies for the diagnosis of cancer. The new antibodies against PMS2 (clone EP51) and CK5 (clone EP24), are rabbit polyclonal immunohistochemistry (IHC) grade antibodies and …